Division of Microbiology, Kobe University, Graduate School of Medicine, 7-5-1 Kusunoki-cho, Cyuo-ku, Kobe, Hyogo 650-0017, Japan.
Microbes Infect. 2012 Jan;14(1):69-78. doi: 10.1016/j.micinf.2011.08.009. Epub 2011 Aug 31.
The lack of a culture system that efficiently produces progeny virus has hampered hepatitis C virus (HCV) research. Recently, the discovery of a novel HCV isolate JFH1 and its chimeric derivative J6/JFH1 has led to the development of an efficient virus productive culture system. To construct an easy monitoring system for the viral life cycle of HCV, we generated bicistronic luciferase reporter virus genomes based on the JFH1 and J6/JFH1 isolates, respectively. Transfection of the J6/JFH1-based reporter genome to Huh7.5 cells produced significantly greater levels of progeny virus than transfection of the JFH1 genome. Furthermore, the expression of dominant-negative Vps4, a key molecule of the endosomal sorting complex required for transport machinery, inhibited the virus production of JFH1, but not that of J6/JFH1. These results may account for the different abilities to produce progeny virus between JFH1 and J6/JFH1. Using the J6/JFH1/Luc system, we showed that the two polyanions heparin and polyvinyl sulfate decreased the infectivity of J6/JFH1/Luc virus in a dose-dependent manner. We also analyzed the function of microRNA on HCV replication and found that miR-34b could affect the replication of HCV. The reporter virus generated in this study will be useful for investigating the nature of the HCV life cycle and for identification of HCV inhibitors.
缺乏能够高效产生子代病毒的培养体系一直阻碍着丙型肝炎病毒(HCV)的研究。最近,新型 HCV 分离株 JFH1 及其嵌合衍生株 J6/JFH1 的发现,为开发高效的病毒生产培养体系铺平了道路。为了构建 HCV 病毒生命周期的简便监测系统,我们分别基于 JFH1 和 J6/JFH1 分离株构建了双顺反子荧光素酶报告病毒基因组。与 JFH1 基因组转染相比,J6/JFH1 报告基因组的转染可显著提高子代病毒的产量。此外,表达显性负性 Vps4(一种内体分选复合物必需的运输机制的关键分子)可抑制 JFH1 的病毒产生,但不抑制 J6/JFH1 的病毒产生。这些结果可能解释了 JFH1 和 J6/JFH1 产生子代病毒能力的不同。利用 J6/JFH1/Luc 系统,我们发现两种多阴离子肝素和聚硫酸酯以剂量依赖的方式降低了 J6/JFH1/Luc 病毒的感染力。我们还分析了 microRNA 对 HCV 复制的功能,发现 miR-34b 可影响 HCV 的复制。本研究中生成的报告病毒将有助于研究 HCV 生命周期的本质和鉴定 HCV 抑制剂。